Physician

Scott Stoerner, MD

According to 2025 Medicare claims, Scott Stoerner, MD (NPI: 1053507715) practices rheumatology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495. Stoerner is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Stoerner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 297 traditional Medicare patients, billed 52,351 HCPCS/CPT codes, and received $936,625 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,781 prescription claims across 495 beneficiaries totaling $3,034,054 in drug costs, led by Enbrel Sureclick (Etanercept). 2015 DME data shows 12 claims. Open Payments data shows 34 records totaling $558. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $469,887 to $936,625. Similarly, Part D prescription costs have moved sharply higher in recent years, from $336,240 to $3,034,054. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.